Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI is a promising company with a positive outlook due to its focus on a large and under-penetrated market, the potential for recurring revenue through its licensing model, and strong clinical performance in studies. The recent funding from BARDA further solidifies the company's financial position and its progress towards commercialization. Risks to consider include competition, limited reimbursement, and potential setbacks in regulatory and clinical timelines. Overall, Spectral AI has the potential to become a successful and stable growth company in the AI and MedTech space.

Bears say

Spectral AI is a company focused on medical diagnostics using AI, however their financials show a declining trend in profitability with increasing expenses and a reliance on government contracts for revenue, leading to a risky investment outlook. Their recent FDA clearance for the DeepView System for burn centers, trauma centers, and emergency departments is a positive milestone, but it remains to be seen if they can successfully commercialize the product and drive sustained revenue growth.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of Aug 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.